Chitin, the second most available marine biopolymer, was firstly used in the 1930s and early 1940s. [1-4] It has a linear structure that is composed by repeating β-1,4 linked N-acetylated glucosamine units [2, 3, 5, 6]. Chitosan, derived from chitin, is a natural polymer that is known for being biodegradable, non-toxic and antibacterial [1, 2, 4, 7-12]. It is cationic, has a hydrophilic surface and causes minimal foreign-body reaction [1, 6, 7, 10, 11, 13-17]. Also, chitosan shows a reasonable solubility in water and in organic acids. However, this represents the major limitation to chitosan's preparation and use for biomedical applications.[1, 4, 6, 10, 14-16, 18] Due to these properties it can be used for drug delivery, cancer diagnosis, immune regulation, tissue regeneration (treatment of damaged skin, nerve regeneration, cartilage and bone repair) and as antioxidant and anti-inflammatoryy [3, 4, 11, 13, 15, 17]. Also, shows an antitumor and antidiabetic capacity and haemostatic effects [5, 19, 20]. In what Dental medicine is concerned, chitosan is very useful too. Due to its bone regeneration capacity, it can be used as a therapy for alveolar bone repair, as well as in the implantology field. [7, 8, 21-23] Because of its antimicrobial effect, is very promising in endodontic treatment. [24] Also, it promotes a higher resistance to fungal diseases and leads to better effectiveness on decay remineralization [13, 14, 17]. In addition, although numerous treatments are used to regenerate the alveolar bone, cementum, and loss of periodontal ligaments (PDL), Chitosan-based therapies are used to treat periodontal lesions [17]. To conclude, chitosan is an innovative biomaterial which use has been increasing exponentially over the last years. Thus, the aim of this review is to study chitosan's biomedical applications, especially in what concerns to Dental Medicine.

Keywords: chitosan; chitin; biomaterials; biomedical application; tissue regeneration; drug delivery.

The commercial applications of chitin arose in the 1930s and early 1940s but it was first identified in 1884. [1, 2]

Chitin consists of a marine biopolymer which is the second most available in nature (the main one is cellulose) [2-4]. It has a linear structure that is composed by repeating β-1,4 linked N- acetylated glucosamine units. [2, 3, 5, 6]

Chitin can occur as α, β or γ forms. Each one has its own structural properties:

• The α form has microfibril with an antiparallel orientation which are linked by strong hydrogen bonds. In nature, it is the most common form and is the best one for the industry.
• The β form, unlike α, has its chains parallel orientated (linked by weak hydrogen bonds).
• The γ form, that is the less known, consists of a mixture of antiparallel and parallel chains.

Due to strong hydrogen bonds present in α- chitin, it is insoluble in water, most organic acids and dilutes the acid and alkaline solutions. On the other hand, since β-chitin has weak hydrogen bonds, it has better solubility in most acids and swells up in the water. [4]

This polymer can be found in cell walls of yeasts and fungi, shells of crustaceans, corals, diatoms sponges, molluscs, the cuticles of insects and worms, however, the major commercial sources of chitin are crab and shrimp shells. [1, 5, 6, 14, 25] Bearing this in mind, chitin extraction from shells unable us to minimize the waste, as well as to produce compounds with valuable biological properties and specialty applications, such as chitosan [1, 4].

In order to find reliable articles to base this review on, the research was done in the database Pubmed.

As a starting point, we used the terms "Chitosan collagen membrane". As a result, we obtained 174 articles. Posteriorly applying filters, such as "5 years" and "free full-text", this number reduced to 17, from which we chose 10 after reading their abstract.

Once the number of articles we obtained was insufficient to elaborate a review, we were forced to enlarge de research and, consequently, the theme, looking for more embracing terms.

Therefore, in the second phase, we searched for "Chitosan". It resulted in 21608 articles, a number that reduced to 63, after applying for the filters "review", "free full-text", "5 years" and "humans". From those, 13 were found pertinent by Reading the abstract.

Secondly, "chitosan membrane" was the expression searched. 2759 articles were gathered, resulting in 12 after using the filters "review", "free full-text" and "5 years". Due to reading the abstract, the number of selected articles decreased to 5.

In another research, we searched for "Chitosan membrane AND dentistry". We found a total of 56 articles. After using the words "free full- text" and "5 years" as filters, 8 articles remained, which became 4 after reading the abstract.

Ultimately, "Chitosan scaffold AND dentistry" was the expression we looked for. 75 documents were founded, however, only 2 were selected by reading the abstract. The filters used were "free full-text" and "5 years". To conclude, some articles were common to the different researches that we made. Those were only considered once.

Chitin is transformed into chitosan, its main derivative, by partial deacetylation under special conditions like a strongly alkaline environment. Chitosan is a linear amino polysaccharide composed of β(1→4) glycosidic bonds linking, randomly distributed, D- glucosamine, and N-acetyl-D-glucosamine monomers. [5-8, 16, 25, 26] It is structurally similar to the glycosaminoglycans in the extracellular matrix. [8, 11]

Deacetylation can be performed by enzymatic preparations or chemical process, being the last one the most used because of its low cost and as it allows massive production. (1)

Chemical deacetylation can be performed by acids or alkalis. However, as glycosidic bonds are very susceptible to acid, alkalis (such as NaOH) are more often used. Depending on the NaOH concentration, reaction time, temperature and repetition of alkaline steps, final chitosan may have different characteristics, such as degree of deacetylation (DA) and molecular weight (MW). Other factors may be taken [5] into consideration: atmosphere, reaction reagent, chitin and solvent ratio, particle size and source of raw material. Despite its advantages, chemical deacetylation has some cons like energy consumption and waste of concentrated alkaline solution. As a result, enzymatic deacetylation has occurred. [1, 25]

Enzymatic deacetylation uses chitin deacetylases to perform a controlled, non- degradable process that allows us to obtain a novel, well-defined chitosan. Such enzymes are glycoproteins which are found in several insect species and fungi. They are extremely stable at 50 °C and show an excellent specificity for β- [1,4]-linked N-acetyl-D-glucosamine polymers. Nevertheless, chitin substrates need to be pretreated so that the accessibility of the acetyl groups to the enzyme can be improved [1].

The process and therefore the degree of deacetylation is determinant for the establishment of chitosan characteristics. [16] Chitosan is a very interesting polymer as it is biodegradable, non-toxic, biocompatible and has antibacterial effects, that can promote the acceleration of wound healing. It has high adsorption, is capable of forming three- dimensional porous structures, is easy to handle and has a low cost. Moreover, chitosan has mechanical stability, especially when associated with collagen. [1, 4, 6, 10-12, 14, 18] It is a cationic polymer at low pH (an exception since other polysaccharides are generally neutral or anionic) which gives it a great affinity for anionic molecules. Therefore, chitosan can bond with mucous tissue (mucoadhesiveness), being a good option for tissue engineering [1, 6, 10, 13-16]. In addition, its hydrophilic surface promotes cell adhesion, proliferation, and differentiation and causes a minimal foreign- body reaction on implantation. [7, 11, 17]

As mentioned above, the DA and MW influence, to a great extent, chitosan characteristics like crystallinity, solubility, and its mechanical performance. This polymer has low molecular weight and a high degree of deacetylation. As a result, chitosan shows a reasonable solubility in water (that can be improved by chemical modification) and inorganic acids. This last characteristic represents the major limit to chitosan preparation and uses for biomedical applications. [1, 4, 6, 10, 14-16,18].

Due to these properties, chitosan has even more applications. It is very useful for drug delivery, cancer diagnosis, immune regulation, treatment of damaged skin, nerve regeneration, cartilage and bone repair, antioxidant properties and anti-inflammation. [3, 4, 11, 13, 15, 17] Also, shows an antitumor and antidiabetic capacity and hemostatic effects (as its cationic nature attracts the anionic blood cells and platelets allowing it to be used in postpartum hemorrhage, dental surgery, and other surgical applications). [5, 19,20] Besides that, chitosan can interact with substances like collagen, heparin, hyaluronic acid, gelatine, alginate and minerals: [21, 25]

• Hydroxyapatite maximizes the in vivo osteogenic capacity which leads to an internal bone growth with accelerated resorption of the matrix. (16, 21)
• Calcium aluminate also has an important role in bone regeneration (it releases Ca2+ that increases osteogenesis and cementogenesis). In addition, it improves chitosan's mechanical strength, which is required for scaffolds. [21]

Despite all the information known about this biomolecule, the lack of clinical studies in humans requires more and deeper studies on this matter.

Chitosan and its different morphologies Depending on environmental pH values and degree of acetylation, chitosan can display different ways of production. At low pH (< 6), amines are protonated, exhibiting a polycationic nature (contributes to creating multilayer structures and/or electrostatic complexes). At high pH (>6.5), chitosan amines are deprotonated and reactive, promoting interpolymer associations. These associations lead to film, fibre, porous templates or hydrogel formation. [2, 20, 27, 28] It can also be presented as sponge, powder, bead, solution, foams, microcapsules, tubes, membranous films, nanofibers, scaffolds, nanoparticles. [2, 11, 16, 18, 22, 25]

Scientific literature supports that bacterias are unable to form biofilm by chitosan nanoparticles. [24] Additionally, scaffolds are very useful in bone, skin (also regenerated using fibers and hydrogels), liver, cartilage, nerve, and blood vessel wounds. Fibers and hydrogels allow migration of inflammatory cells to the wound site and collagen matrix deposition. Furthermore, hydrogels have the capacity to promote angiogenesis. [3]

Natural occurring biomaterials (like chitosan and collagen) and Calcium phosphate ceramics (like hydroxyapatite) are commonly used for tissue regeneration. Chitosan, due to its properties, is a great material to form different platforms where cells can adhere, grow in and differentiate. [9, 10, 18]

Nevertheless, several studies proved that better results were achieved when chitosan was combined with collagen in comparison with pure chitosan. [9, 16]

In addition, hydrogels can be used to produce scaffolds that have as advantages: minimal physical flexibility, invasive procedure, and easiness of incorporating cells. However, one of its disadvantages is that some cells have a lack of adhesion to scaffolds. Dhanya et al. prepared a new scaffold, O-carboxymethyl chitosan (O- CMC), as an attempt to solve this limitation. It has high viscosity, good water solubility, and high hydrodynamic volume. [18]

Moreover, chitosan-based platforms can also be used in a more delicate area, such as cardiac patch for defects in myocardial tissue. Pok et al. prepared a gelatin-chitosan hydrogel-based multilayer cardiac patch. This compound (which the main component is chitosan) increases patch tensile strength and, due to gelatin, consolidates cell attachments. [18]

Another study has been developed to investigate in-vitro and in-vivo degradation rates of porous freeze gelated chitosan (CH) and chitosan hydroxyapatite scaffolds. It is believed that scaffold's pore architecture is essential to an efficient cell seeding into the scaffold. Simultaneously, it may offer enough space for the regeneration of newly formed tissue. Therefore, those two characteristics should be taken in consideration when chitosan scaffold is being produced. Biomaterial degradation rate may, also, be taken into account. It might be sustained enough so that healthy tissue regeneration can be fulfilled [28].

Chitosan hydroxyapatite scaffolds are stable and biodegradable (however its degradation rate is lower). Additionally, they provide an osteoconductive environment for bone formation and have a high elastic modulus. These are the reasons why they are appropriate to bone substitution and regeneration in dental implants [28].

On the other hand, scaffolds are favorable for tissue regeneration if they show a highly porous structure to support cellular adhesion and proliferation and extracellular matrix (ECM) production. Their degradation is dependent on pore morphology and size, porosity percentage, surface area, and hydrophilicity. Porous freeze gelated chitosan scaffolds have been tested in order to be used for periodontal regeneration [28].

Peter et al. and Mota et al. concluded that degradation rate of chitosan can be reduced by adding compounds (such as Bioglass™), what can contradict one of the major limitations of its use for tissue regeneration. Therefore, the conclusions of these studies prove the enormous chitosan and hydroxyapatite potential for use in composites that aim bone tissue engineering applications [28].

Even so, the lack of precise information about chitosan's characteristics, its large chemical variability and studies' methodological limitations make it difficult to reproduce and standardize its clinical application. [10]

Inflammation is a crucial part of healing, however, it encumbers tissue regeneration when we are dealing with chronic wounds or biomaterial implantation. [3]

Until known, in order to decrease the inflammatory response, biomaterials have been incorporated with anti-inflammatory therapeutics. Therefore, new scaffolds' designs aim to provide instructive signals for cell attachment, function and proliferation within the native tissue and to modulate the immune response. [3]

Chitin-derived materials, such as chitosan, were discovered to be effective to chronic inflammatory diseases treatment (inflammatory bowel disease, arthritis, sepsis, and asthma, for example) as they are useful for drug delivery and in modulating immune responses (it attracts macrophages and neutrophils to the wound, monitoring inflammatory response and reepithelization). Their mechanism, although not fully defined, consists of molecules degradation into monosaccharides, accelerating wound healing. [3, 18].

Autografts have been used to treat peripheral nerve damage, but they have many disadvantages. Therefore, chitosan is an excellent option to treat this condition as hydrophilicity is considered to be essential for preventing fibrous scar tissue invasion and for promoting nerve regeneration. Nerve conduits formed by this biopolymer have better mechanical properties and slow biodegradability. [29]

Recently, porous hybrid membranes (such as chitosan- -glycidoxypropyltrimethoxysilane - chitosan-GPTMS) were investigated for peripheral nerve regeneration. They were proven to significantly improve nerve fibre regeneration and its functional recovery in rat models by demyelination. The quantity of regenerated myelin fibres increased, as well as, myelin thickness [29].

Chitosan can play an important role in the prevention and treatment of age-related diseases. Among others, it can prevent protein conformational diseases and treat those which result from oxidative stress. Researchers from Fukuyama University conducted in vitro and in vivo studies and concluded that, by decreasing oxidative stress (it suppresses the formation of reactive oxygen species), chitosan can have a direct antioxidant effect in the systemic circulation. [5, 19]

Chitosan oligosaccharides (COS) are also used in order to treat neuronal disorders, including Alzheimer's disease, Parkinson's disease, and nerve crush injury. Owing to their shorter chain lengths, COS are rapidly soluble in water which confers them new properties like being neuroprotective (such as β-amyloid and acetylcholinesterase inhibitory activities), anti- neuroinflammatory and having anti-apoptosis effects. Moreover, Gong et al. explored the effects of this polysaccharide on nerve regeneration after peripheral nerve injuries. As a result, they concluded that it could enhance the quantity of regenerated myelinated nerve fibres, the cross-sectional area of muscle fibres, the muscle action potentials and the thickness of regenerated myelin sheaths in the nerves. [5]

Nowadays, neuroprotection aims to limit neuronal dysfunction or death after nerve injury. For that, neuroprotective agents like antioxidants and anti-inflammatory agents are used. The problem is that synthetic agents are linked to several side effects. Therefore, anti-neuronal disorders agents with low toxicity have been studied. [5]

To conclude, Chitosan and its derivatives are neuroprotective through mechanisms like antioxidative stress action; suppressing effect on Abeta aggregation; anti-neuroinflammatory action; anti-apoptosis action; anti-excitotoxic action. [5]

A cancer diagnosis is a crucial step since it gives some information about treatment effectiveness. Theragnosis is a new concept which combines molecular imaging (through nanoparticles that are accumulated in tumor tissue) and anti-cancer drugs that are encapsulated into nanoparticles. In this line of thought, chitosan is ideal for nanoparticle-basedd theragnosis, as it can be easily transformed into nanoparticles and self- degradable after accurate diagnosis and drug delivery [6].

In this field, chitosan has several applications, especially when prepared into nanoparticles. This biomaterial can be an ideal vaccine adjuvant due to its cationic nature, biocompatibility, safety and its ability to be used as an antigen carrier. It also showed a superior immune activity when compared to traditional immunoadjuvants, as chitosan retains the peptide antigen in the administration site for a longer period, allowing the antigen to be presented for efficient immune activity [6].

Anti-cancer drugs used in chemotherapy have several severe side effects, due to the low specificity to the tumor tissue and their systemic administration. To minimize this non- specificity therapy, selective embolization has been studied. It provides angiogenesis that will affect cancer cells viability (it occludes arteries formed by those cells, inducing tumor's cells starvation). Chitosan is not a viable candidate to this approach since it is weak when produced into microspheres. [18] Chemoembolization is a method that occurred later described by Park et al. It combines the effect of embolization with sustained release of the anti-cancer drug. They accomplished an efficient in vivo anti-cancer effect with a reduction of one-third of the initial tumor size. [18]

Chitosan is soluble in acidic conditions, unlike neutral or basic ones. Yuka et al. suggested that it can be chelated with several substances and then injected (as an acidic solution- 166Ho- chitosan complex) into human organs. It forms a solid structure that consists of a radioactive pharmaceutical device, allowing radioactivity to be localized in the administration site (when intratumorally and intrahepatically injected) [18].

The presence of amino groups with positive charge allows chitosan to promote chemical and physical cross-linking (chitosan can adhere to negatively charged organs' surface), which is the main advantage of its use. In addition, if chitosan is modified with hydrophobic groups, it can be used to encapsulate hydrophobic drugs, since it forms intra- and intermolecular interactions [1, 18].

Therefore, chitosan can be a successful carrier for many different therapeutic agents: proteins, peptides, growth factors, DNA, vaccines, anti-inflammatory, antibiotics, and other drugs for parental and non-parental routes of administration (like oral, ocular, topical, nasal, transdermal and pulmonary) [27]. Although the many forms of chitosan formulations, the choice to use a micro or a nanoparticle depends on what is required. For example, since microparticles cause obstruction in the blood vessels, nanoparticles are the best choice for intravenous delivery. On the other hand, if nanoparticles are used to pulmonary delivery (to treat different pulmonary infections and diseases, like tuberculosis) they would be exhaled. So, in this case, the use of microparticles would be better [1, 27].

Both chitosan's micro and nanoparticles, when loaded with antibiotics and administrated by the oral route, can be used in the treatment of gastrointestinal and systemic diseases, such as ulcerative colitis, irritable bowel syndrome, Crohn's disease and suppression of Helicobacter pylori. Drug colon targeting is useful since the degradation of chitosan is done by the specific local microflora [27].

Bone regeneration is important to orthopedic, maxillofacial, and oral surgery (such as in periodontology and implantology field) in order to correct the bone defects. Therefore, the density and bone volume must be recreated, without forgetting the function. At the moment, therapies use bone tissue's grafts from different kind of origins – heterologous, homologous or autologous (each one of them with advantages and disadvantages). As autologous grafts (which have no risk of rejection and diseases transmission) are limited, a new approach for bone regeneration is needed. [7, 8, 12, 13, 16, 21]

Furthermore, the biomaterials have been studied because of their capacity to induce a biological response, knowing that the results obtained are satisfactory. Nowadays, guided bone regeneration (GBR) is a therapy for alveolar bone repair using a membrane which has the ability to prevent the formation of fibrous connective tissue [7, 8, 21, 22]. The membrane has some properties like bioactivity (promotes cellular migration, proliferation, and infiltration), biocompatibility, bioresorption, lack of cytotoxicity and stability. This membrane can be combined with natural polymers (collagen and chitosan). The degradation rate of polymers is also a crucial factor: it should be total and not require a second surgical intervention. That is why it may have a long-term influence on the success of bone regeneration [7, 12, 22].

According to Jiayu Zhang et al. [22] local drugs delivery systems (DDS) allow aspirin to be in the right place at the correct moment. As a result, there will be a reduction in the number of administrations, bacterial resistance, gastrointestinal effects and we can avoid variations of large concentration. [22]

Non-steroidal anti-inflammatory drugs (NSAID) are reported to be effective in: repair of bone defects and fracture (bear in mind that dose is an important factor), reduce the percentage of tissue destruction and bone loss in periodontal disease [22].

The results show a good controlled-release pattern, the biocompatibility and osteogenic potential of the membranes and also a significant increase of bone, in animal models. [22] On the other hand, GBR membranes are vulnerable to infection because of their exposure to pathogenic agents, which affects bone regeneration. In an attempt to counteract this, it is used antibiotic ointments. However, it should be created a new antibacterial GBR membrane. (8) Shiqing Ma et al. [8] used membranes containing antibacterial agents such as tetracycline, chlorhexidine, minocycline, and amoxicillin. These ones have the ability to inhibit bacterial proliferation and induce the growth of fibroblasts and osteoblasts, as well as, stimulate angiogenesis. [8]

An asymmetric collagen/chitosan GBR membrane (CCM membrane) was carried with encapsulated minocycline. This membrane had loose chitosan (that allows it to be osteoconductive) and dense collagen layers (act as a physical barrier), low degradation and activity against Fusobacterium nucleatum and Porphyromonas gingivalis, which are the core of periodontitis disease [8].

CCM membrane promoted new bone formation. In addition, there weren't verified inflammatory reactions and grade of degradation has raised. Furthermore, it was observed a huge number of mesenchymal stem cells and capillary vessels (responsible for transportation of nutrient and stem cells), which is an ideal environment of osteoinduction [8]

Jae Min Song et al. [7]. reinforced that chitosan/fibrin–hydroxyapatite (CFB–HAP), a membrane that has also been studied, promotes haemostasis and adhesiveness and is biocompatible, anti-infective, resorbable and plastic. [7] After this study, it is possible to affirm that the bone repair capacity is similar between CFB–HAP membrane and collagen membrane. In addition, the absorbable chitosan membrane can be used as a barrier membrane in GBR. However, the inflammatory reaction didn't exist in the CFB-HAP, which can comprise the success of the guided bone regeneration [7].

The endodontic treatment has a significant percentage of failure, associated with inefficient decontamination of root canals and repair of changes caused by the disease [24].

In this context, antimicrobial photodynamic therapy (PDT) has been used as it promotes cross-linking between collagen and proteins and has a large spectrum of antimicrobial activity. Also, some nanoparticles like chitosan, which is able to reduce the bacterial-biofilm, have been modified with a photosensitizer (such as rose Bengal, that produces synglet oxygen) in order to highlight PDT. As a result, bioactive polymeric chitosan nanoparticles functionalized with rose-bengal (CSRBnp) were studied to eliminate biofilms and stabilize the matrix (dentin-collagen) attending to its positive charge and nano size. Those characteristics, also promote a Physico-chemical interaction with some other particles [24].

The conjugation of this cationic molecule with photosensitizer allowed the penetration on the bacterial membrane. These cells were efficiently killed, as well as their biofilm structure destroyed. The antibacterial effects of chitosan are based on promoting bacterial membrane damage, increasing its permeability and providing intracellular leakage [24]. In addition, chitosan nanoparticles have been incorporated into root canal sealers in order to reduce the biofilm formation and inhibit microbial penetration in the dentin-root [13].

In another view, pulp exposure can be treated without chemical injury to pulp cells. For that, it was tested a chitosan/collagen membrane combined with calcium-aluminate microparticles. The results were: an increase of human dental pulp cells proliferation, trailed by odontoblastic phenotypes (high expression) and intensive deposition of matrix's mineralized [30].

The tooth extraction is associated with resorption of alveolar bone in a period of three months. Residual ridge absorption is a real problem to posterior rehabilitation of the edentulous area because of the lack of bone support. Any solution present has to promote osteogenesis and also angiogenesis. [23]

The core is to preserve the level of bone in order to realize a functional and aesthetic restoration. A dental implant is used to replace multiple or single missing teeth or to support a prosthesis. The lifetime of a dental implant is limited by its capacity to uptake and hold backwater, which is related to diffusion's coefficient of the material. [23, 28].

One of the proposals is to use Poly (L -lactic-co-glycolic) acid and nanohydroxyapatite together with chitosan to delivery adrenomedullin (ADM). It was reported that ADM is a substance which promotes the mitogen activity and proliferation of osteoblasts. Besides that, it seems like a promising new formula for bone regeneration, once it increases the formation of new bone tissue and is capable of stabilizing the residual alveolar ridge [13, 23].

It is known that chitosan has activity against oral pathogens such as Prevotella intermedia, Porphyronomasgingivalis, and Actinobacillus actinomycetemcomitans, inhibiting the bacterial plaque formation. To some authors, this inhibition can occur as chitosan nanoparticles kill the bacteria or have a direct action in the bacteria-substrate. Additionally, it has been reported that the collagen's turn over has increased when chitosan is present. In this line of thought, toothpaste could contain chitosan nanoparticles, in order to reduce bacterial biofilm formation [13, 17].

Chitosan nanoparticles can be used to remineralize dentine and enamel caries. This occurs because chitosan's nanoparticles, at a neutral pH, cause damage in cariogenic microorganisms, such as S.mutans' cells. [13] There are studies using nanocomplexes of carboxymethyl chitosan/amorphous calcium phosphate (CMC/ ACP) to remineralize the dentine via biomimetic strategy. This remineralization is more difficult to occur due to dentine's organic matrix when it is compared to enamel. In addition, the remineralization of dentine happens by its residual crystals' growth. Using a single-layer model, CMC/APC released ACP nanoparticles to achieve intrafibrillar mineralization forms of collagen (the minerals are deposited in the collagen fibril's gap zones and microfibrillar space) - bottom-up strategy. The remineralization of demineralized dentine happens preserving the greatest extent possible of dentinal tissue when this combination is used [31].

In the last few decades, the number of cases with microbial infections increased exponentially, possibly due to the raise of immunosuppressive diseases or infections (eg. leukemia or AIDS), as well as secondary effects from cancer chemotherapy. Moreover, the resistance of pathogenic microorganisms to conventional treatment has also increased due to primary or secondary resistance [14]. Chitosan acts against the growth of hyphal, filamentous fungi and yeast infection (human), as well as spore germination. The plasma membrane of fungi (phospholipid heads and glycoinositolphosphorylceramides), that is composed of polyunsaturated fatty acids, is the target of chitosan. [14] It is important to take into consideration that the more fluid the membrane is, the more sensitive will be to the fungicides. Therefore, some fungi are resistant to chitosan because they have a low concentration of polyunsaturated fatty acids, such as P. chlamydospores, nematophagous and entomopathogenic fungi [14].

Chitosan can be used against Candida spp. and has the potential to, in the future, reduce the use of antifungals, such as amphotericin B and fluconazole [14]. Chitosan-coated nanoparticles (CS-NPs) containing fluconazole (FLZ) were tested for local treatment. The results show that the CS- NPs interact with mucins, extend the delivery of the drug and promote animals' recovery from candidiasis. FLZ remains in the mucosa to act locally and it isn´t absorbed to the systemic circulation. [18, 32] Due to this, this formulation hasn´t a cytotoxic effect and can eliminate the chance of drug interaction when is compared to systemic therapy with FLZ [32].

Although numerous treatments are used to regenerate the alveolar bone, cementum, and loss of periodontal ligaments (PDL), new approaches are required to treat periodontal lesions [17].

Porous membranes of chitosan, combined or not with hydroxyapatite, were prepared using freeze gelation (FG). They were to be used for GTR (guided tissue regeneration) to increase periodontal recovery. They are unique due to their physicochemical properties, ultrastructural morphology, degradation, mechanical properties and biocompatibility [20].

In this study, it was demonstrated that porous membranes would be used as a core layer and that the selection of solvent and quantity of incorporated HA benefited the properties (chemical and physical) of membranes. Additionally, it was observed the resilience of the membranes while they were handling in wet and dry conditions. The cellular response was positive, which indicates that cellular activity was affected by HA incorporation. [20] Some other applications of chitosan are succinctly explained in the table below.

In this review, the applications of the biopolymer chitosan were highlighted in the medical field, including dentistry. Thanks to its properties, such as biocompatibility and biodegradability, its cationic nature, it's non- toxic and antibacterial effects and the fact that causes a minimal foreign body reaction, chitosan is a useful biomaterial in drug delivery, immune regulation, tissue regeneration, cancer diagnosis, among many other. Particularly in dentistry, it has application in bone regeneration, alveolar bone repair and in the implantology field. It's also very promising in endodontic treatment (since it has an antibacterial action), decay remineralization and treatment of fungal diseases and periodontal lesions.

In the near future, this innovative biomaterial, which research has been increasing exponentially in the last years, can be very helpful in the diagnosis and treatment of many prevalent diseases. Nevertheless, more studies are needed, in order to its mechanism of action and applications are fully understood and known.